-+ 0.00%
-+ 0.00%
-+ 0.00%

THERAVANCE BIOPHARMA INC - RETAINS RIGHTS TO UP TO $150 MLN IN MILESTONES FROM ROYALTY PHARMA ON TRELEGY ELLIPTA NET SALES IN 2025 & 2026

Reuters·06/02/2025 10:00:07

Please log in to view news